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Abstract
Spinal muscular atrophy (SMA) is caused by deficiency of the ubiquitously expressed survival motoneuron (SMN) protein.
SMN is crucial component of a complex for the assembly of spliceosomal small nuclear ribonucleoprotein (snRNP) particles.
Other cellular functions of SMN are less characterized so far. SMA predominantly affects lower motoneurons, but the cellular
basis for this relative specificity is still unknown. In contrast to nonneuronal cells where the protein is mainly localized in
perinuclear regions and the nucleus, Smn is also present in dendrites, axons and axonal growth cones of isolated
motoneurons in vitro. However, this distribution has not been shown in vivo and it is not clear whether Smn and hnRNP R
are also present in presynaptic axon terminals of motoneurons in postnatal mice. Smn also associates with components not
included in the classical SMN complex like RNA-binding proteins FUS, TDP43, HuD and hnRNP R which are involved in RNA
processing, subcellular localization and translation. We show here that Smn and hnRNP R are present in presynaptic
compartments at neuromuscular endplates of embryonic and postnatal mice. Smn and hnRNP R are localized in close
proximity to each other in axons and axon terminals both in vitro and in vivo. We also provide new evidence for a direct
interaction of Smn and hnRNP R in vitro and in vivo, particularly in the cytosol of motoneurons. These data point to
functions of SMN beyond snRNP assembly which could be crucial for recruitment and transport of RNA particles into axons
and axon terminals, a mechanism which may contribute to SMA pathogenesis.
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Introduction
Proximal spinal muscular atrophy (SMA), the most common
form of motoneuron disease in children and young adult, is caused
by deficiency or loss of function of SMN [1]. The SMN protein is
widely expressed and plays a central role in the formation of
spliceosomal uridine-rich small nuclear ribonucleoprotein (U
snRNP) complexes [2]. Recent studies with fly models have
provided evidence that defects of pre-RNA splicing in sensory
neurons contribute to the pathogenesis of SMA [3]. In SMA
patients, motoneurons are primarily affected. Other organs and
even most other types of neurons in the central and peripheral
nervous system are spared or much less affected, thus raising the
question about the molecular mechanisms underlying the high
vulnerability of motoneurons. Degeneration and dysfunction of
axon terminals at neuromuscular endplates is a prominent
hallmark in SMA [4–8]. Weakness of the proximal musculature
is an early feature in SMA patients and this correlates with defects
in neurotransmission at neuromuscular junctions (NMJ) [9,10].
Similar observations have been made in mouse models of SMA
[11–14] and in isolated SMA type I motoneurons, which
developed defects in presynaptic differentiation and axonal
excitability [15].
In most cell types, the SMN protein is found both in the
perinuclear cytoplasm, where spliceosomal snRNP complexes are
assembled, and in specific structures within the nucleus called
Gemini of coiled bodies (Gems) [16], where such RNP particles
are regenerated and processed [17]. In cultured motoneurons Smn
is also found in cytoplasmic granules within neuronal processes
and in axon terminals [18–20]. For its function in the assembly of
spliceosomal U snRNP particles Smn associates with Gemin 1 to 7
and Unrip [21–23]. This complex assembles Sm core proteins and
small nuclear RNAs into snRNPs [24,25]. SnRNP particles are
then transported back into the nucleus [26]. This function of Smn
appears crucial for all cell types. Full knockout of the murine Smn
gene results in early lethality [27], which is compatible with
disruption of such an essential cellular function of Smn. The
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presence of a second SMN gene (SMN2) in humans gives rise to
low amounts of functional SMN protein. This specific condition
appears responsible for the observation that most organs are
unaffected, whereas motoneurons become dysfunctional and
degenerate [28]. Recent in vitro studies have detected Smn in
association with components of the classical SMN complex, such
as Gemin 2 and 3, in axons of cultured motoneurons and other
types of neurons [15,20]. However, Smn also associates with
several other proteins which are not part of the SMN complex like
HuD or hnRNP R [18,19,25,29], the fragile X mental retardation
protein (FMRP) [30], the ALS-related proteins FUS and TDP43
[31–34], and several other members of the heterogeneous nuclear
ribonucleoprotein family [35]. These complexes bind mature
mRNA species in motoneurons [20,36], including ß-actin mRNA
[19]. The interaction of Smn and hnRNP R appears particularly
interesting since knockdown of hnRNP R in zebra fish or in
isolated motoneurons [29] causes similar defects in motor axon
growth as the depletion of Smn [37], indicating that the
interaction of these two proteins is relevant in the context of
axonal defects and dysfunction of axon terminals in SMA.
However, these studies did not provide an answer on whether
Smn is also present in axons and axon terminals of developing and
postnatal motoneurons in vivo, and whether the association with
hnRNP R is direct and developmentally regulated. In order to
address these questions, we studied the subcellular distribution and
interaction of Smn and hnRNP R in motoneurons both in vitro
and in vivo. We show here that Smn and hnRNP R interact
directly with each other in the cytosol of motoneurons. Further-
more, we provide evidence that both proteins are present in axons
and axon terminals of mouse motoneurons in vitro and in vivo,
supporting the hypothesis that SMN is involved in the axonal
translocation of hnRNP R and hnRNP R-bound protein/RNA
particles, both during embryonic development and after birth.
Results
Localization of Smn and hnRNP R in isolated embryonic
mouse motoneurons in vitro
The assembly of spliceosomal U snRNPs (reviewed in [24,38])
takes place in the cytoplasm surrounding the nucleus. This is the
site where Smn normally is localized (reviewed in [39]) both in
neuronal and nonneuronal cells. Smn is also found in nuclear
structures called Gemini of coiled bodies (Gems) where spliceo-
somal U snRNPs are regenerated [17]. Furthermore, Smn is
located in axons and axon terminals of isolated motoneurons
[15,20]. To confirm this subcellular distribution and to validate
the antibodies used for Smn detection in this study, Smn
immunoreactivity was investigated in primary motoneurons with
and without lentiviral sh-mediated Smn knockdown. Western Blot
analysis verified the specificity of the applied Smn antibodies
showing a robust Smn depletion after shRNA-mediated knock-
down (Fig. 1A). HnRNP R protein levels were not altered when
Smn was deficient (Fig. 1A). Using the same antibody for
immunofluorescent labeling of these motoneurons, Smn was
found in nuclear Gem-like structures and in the cytosol (Fig. 1B).
Motoneurons treated with sh-Smn revealed a significant reduction
of mean Smn signal intensity of 66% (P,0.001, n= 4, N=74) in
the cytosol. Furthermore, the number of Smn-positive Gems per
motoneuron cell body was reduced by 92% (0.0860.02, n= 4,
N= 74, P,0.01) in comparison to uninfected motoneurons
(1.0360.18, n= 4, N= 51). We did not detect any differences
between uninfected and GFP-infected control cells (n = 4, N= 60)
with respect to cytosolic Smn immunoreactivity (1.0260.04) and
number of Gems (0.9760.15).
We then studied the localization of hnRNP R in isolated
embryonic motoneurons. HnRNP R has multiple functions in
transcription regulation and RNA processing (reviewed in
[40,41]). It interacts with Smn and shows high homology with
hnRNP Q [18,19,42,43]. HnRNP R depletion results in defective
axon extension in primary mouse motoneurons and zebra fish [29]
in a similar manner as Smn depletion [37], indicating that
endogenous hnRNP Q cannot compensate for this function. Only
the N-terminus of hnRNP R is distinct from hnRNP Q, and
antibodies against this domain were used to distinguish both
proteins [18] (Supplementary information, Fig. S1A). HnRNP R
contains three consensus RNA-binding domains (RRM1-3) and an
RGG-rich domain, which is typical for many proteins involved in
RNA processing and transport (Fig. S1A). The antiserum directed
against amino acid 1-18 of hnRNP R and termed herein ICN 1-18
(Fig. S1A) stained hnRNP R both in the nucleus and cytosol of
these motoneurons (Fig. 1C). Relatively high levels of the protein
were present in the nucleus when compared with Smn (Fig. 1B,
C). Confocal microscopy of axons and growth cones revealed spot-
like hnRNP R-immunoreactive structures (Fig. 1C). Antibodies
against neurofilament light chain (NF-L) and synaptophysin
(SynPhys) were used to visualize soma, axons and axon terminals,
respectively. Western Blot analysis with the ICN 1-18 antiserum
confirmed the lentiviral shRNA-mediated depletion of hnRNP R
in a dose-dependent manner (Fig. 1D, S1B).
Immunofluorescence analysis after hnRNP R knockdown
revealed also a significant decrease of hnRNP R signal in
motoneuron cell bodies of 52% (P,0.0001, n= 6, N=63)
(Fig. 1E). To further characterize and verify the observed hnRNP
R immunofluorescence we tested an additional antibody against
the N-terminus of hnRNP R. This antibody revealed similar
results with respect to distribution, localization and knockdown
susceptibility (Fig. S1C). Western Blot analysis showed no
significant reduction of Smn expression after hnRNP R depletion
(Fig. 1D). The number of nuclear Smn-positive Gems and levels of
cytosolic Smn immunoreactivity were also comparable between
GFP-infected control and sh-hnRNP R-treated cells (Fig. S1C), as
revealed by immunocytochemical analysis.
Previous studies reported that Smn and hnRNP R can be
coprecipitated from neuronal extracts [18,19,29]. To further
corroborate and characterize this interaction we investigated
potential colocalization and correlation of Smn and hnRNP R in
cell body, axon and axonal growth cone of isolated embryonic
mouse motoneurons by determining both the Pearson’s correlation
coefficient (PCC) and the Manders Overlap Coefficient (MOC)
(reviewed in [44]) (Fig. 2). In order to test whether signals for
maturation of presynaptic terminals influence distribution and
interaction of Smn and hnRNP R motoneurons were cultured
either on laminin-111 (Fig. 2A) or synapse-specific laminin-221/
211 (Fig. 2B) for 5DIV. Highest degrees of Smn/hnRNP R
codistribution were found in the cell body, particularly in the
perinuclear region, on laminin-111 (PCC 0.5960.02; MOC
0.7060.02; n = 6, N= 54) (Fig. 2A, C). In axons (PCC
0.4260.03; MOC 0.5360.03; n= 6, N= 59) and growth cones
(PCC 0.3960.05; MOC 0.5360.04; n= 6, N= 49) a partial
overlap was observed (Fig. 2A, C). When motoneurons were
cultured on laminin-221/211, a condition which leads to
maturation of presynaptic terminals [15,45,46], neither the
subcellular distribution of hnRNP R nor the degree of codistribu-
tion and correlation of Smn and hnRNP R changed significantly
in motoneuron cell bodies (PCC 0.5360.02, P= 0.0582; MOC
0.6760.02, P= 0.0814; n= 6, N= 51), axons (PCC 0.3560.05,
P= 0.1172; MOC 0.5060.03, P= 0.0617; n = 6, N=50) or axonal
growth cones (PCC 0.3160.05, P= 0.1004; MOC 0.4860.02,
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Figure 1. Subcellular distribution of Smn and hnRNP R in isolated embryonic motoneurons. (A) Motoneurons showed reduced Smn
protein levels upon lentiviral knockdown of Smn. Uninfected or GFP-infected mouse embryonic motoneurons were used as controls. Levels of
calnexin and hnRNP R were not affected. For this experiment a C-terminal antibody directed against hnRNP R was used as reported recently [29]. This
antibody recognizes distinct hnRNP R isoforms. (B) Representative images of motoneurons cultured for 7DIV and labeled against Smn (scale bar:
Localization of Smn and hnRNP R in Motor Axon Terminals
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P=0.1060; n= 6, N= 43) (Fig. 2B, C). Similar results were
obtained with an independent N-terminal hnRNP R antibody
with respect to codistribution of Smn and hnRNP R in these
isolated motoneurons (Fig. S1D). To further characterize the
colocalization of Smn and hnRNP R immunofluorescence we used
ImageJ for a colocalization test calculating random PCC values
which reflect a computational non-related random overlap of two
signals. Each colocalization analysis of hnRNP R and Smn
produced a PCC value which was significantly higher than the
corresponding randomized value. Thus, a non-random codistribu-
tion of hnRNP R and Smn can be assumed (for more details see
material and methods).
We then examined whether the subcellular location of hnRNP
R and the colocalization and correlation of Smn and hnRNP R
are regulated over time when motoneurons grow and differentiate
in vitro. We cultured motoneurons on laminin-111 and deter-
mined the localization of hnRNP R and the degree of overlap with
Smn from day 1 to day 7. Previous analyses have demonstrated
that axon elongation in isolated motoneurons from E13.5 mouse
embryos is highest around 4DIV, corresponding to day 18 of
embryonic development [15]. Therefore, we chose 3DIV (Fig. 2D)
and 7DIV (Fig. 2E) as time points for quantitative analysis.
Surprisingly, the subcellular distribution of hnRNP R changed
between 3DIV and 7DIV in motoneuron cell bodies. In
comparison to 3DIV (n= 5, N=37) the relative ratio of cytosolic
versus nuclear hnRNP R immunoreactivity was significantly
increased by 63% (P= 0.0173, n = 5, N=46) at 7DIV (Fig. 2D,
E). This relatively higher number of hnRNP R-positive granules in
the cytoplasm was accompanied by enhanced codistribution and
correlation of hnRNP R and Smn, as detected by colocalization
analysis in motoneuron cell bodies at 7DIV versus 3DIV (PCC
15%, P= 0.0112; MOC 10%, P= 0.0086). Similar alterations
were also observed in axonal growth cones (PCC 18%, P=0.0467;
MOC 8%, P= 0.1565), but not in axons (PCC 7%, P=0.1504;
MOC 5%, P= 0.1449) (Fig. 2D–F). This shift in location and
colocalization coincides with rapid axon extension starting at
4DIV. Interestingly, defects in axon elongation in Smn- [15] or
hnRNP R- [29] deficient motoneurons cultured under similar
conditions are most profound between 4DIV and 7DIV indicating
an important contribution of Smn to the subcellular distribution of
hnRNP R and by this way possibly to axonal outgrowth.
The interaction of Smn and hnRNP R varies between
different cellular compartments
In a further step we investigated whether the interaction
between Smn and hnRNP R is direct (Fig. 3) by expressing
recombinant hnRNP R and SMN in E. coli purifying both
proteins to homogeneity (Fig. 3A–C). This allowed us to test the
interaction of hnRNP R and SMN in the absence of other
proteins. Both proteins could be coimmunoprecipitated when
equimolar concentrations were analyzed indicating that Smn and
hnRNP R interact directly in the absence of other protein binding
partners or RNA (Fig. 3D). HnRNPs are known to form
homomeric interactions [47]. In order to test whether the
formation of hnRNP R dimers influences binding to Smn we
doubled the amount of recombinant hnRNP R in this assay. When
SMN was now pulled down, less hnRNP R was coimmunopre-
cipitated and vice versa, whereas the efficacy of the immunopre-
cipitation itself was comparable between both experimental
conditions (Fig. 3D). The IgG control was negative thus validating
the specificity of the detected interaction (Fig. 3D).
We proceeded to examine whether the interaction of hnRNP R
and Smn differs between cellular compartments (Fig. 4) using
cytosolic and nuclear fractions from isolated motoneurons
(Fig. 4A), E18 spinal cord (Fig. 4B) and HEK293T cells (Fig. 4C).
Motoneurons were cultured for 7DIV on laminin-111 since the
relative proportion of cytosolic hnRNP R and the degree of
overlap with Smn protein was highest at this time point as
described above. Antibodies against histone H3 were used as
marker for the nuclear fraction, and antibodies against a tubulin
and GAPDH for the cytosolic fraction (Fig. 4A–C, right panels).
HnRNP R was found both in the soluble nuclear and in the
cytosolic fraction. Intriguingly, interaction of Smn and hnRNP R
was predominantly detected in cytosolic compartments of cultured
motoneurons (Fig. 4A) and spinal cord extracts (Fig. 4B). Pull-
down of hnRNP R coprecipitated Smn and vice versa.
Smn was not detected in the soluble nuclear fraction (Fig. 4A,
B, input lane), but in the corresponding insoluble nuclear fraction
(Fig. 4B, right panel, lower blot), showing two bands, which may
reflect phosphorylation. Interestingly, the phosphorylation state of
Smn has been described to determine its nuclear localization to
Gems and Cajal bodies [48–52]. In contrast, hnRNP R levels in
this insoluble nuclear fraction are below detection limit indicating
that hnRNP R and Smn are present in distinct compartments
within the nucleus, which argues against a nuclear interaction.
HEK293T cells differed from isolated motoneurons and spinal
cord extracts by showing detectable nuclear Smn levels in soluble
fractions together with hnRNP R (Fig. 4C). In these cells, no
interaction of Smn and hnRNP R was found by coimmunpreci-
pitation, neither in the cytosolic nor in the soluble nuclear fraction
indicating that the interaction of Smn and hnRNP R differs
between neuronal and nonneuronal cells (Fig. 4C).
Localization of Smn and hnRNP R in spinal motoneurons
and neuromuscular endplates
Based on these results we studied distribution and colocalization
of Smn and hnRNP R in spinal cord cross sections from E18
mouse embryos (Fig. 5A) which correlates with the developmental
stage of primary motoneurons isolated at E13.5 and cultured for
5DIV. Motoneurons were identified by choline acetyltransferase
(ChAT) staining. Again, Smn immunoreactivity was mostly found
in the cytosol and in proximal axonal processes, whereas nuclei
appeared relatively spared revealing only distinct Gem-like
immunoreactive structures. In contrast, hnRNP R was detected
both in the nucleus and in the cytosol. In particular, perinuclear
cytoplasm and proximal axons showed an overlap of hnRNP R
and Smn signals (PCC 0.2760.03; MOC 0.8160.01; N= 8)
(Fig. 5A) which is similar to the data obtained by immunofluores-
10 mm). GFP-transfected controls revealed immunoreactive signals for Smn in the cytosol, in neuronal processes and in Gem-like nuclear structures.
Upon lentiviral Smn knockdown both cytosolic Smn immunoreactivity (Uninfected set as ‘1’, n = 4, N= 51; GFP 1.0260.04, n = 4, N= 60; sh-Smn
0.3460.02, n = 4, N = 74; P,0.001, t = 19.19) and number of Gems per nucleus (Uninfected 1.0360.18, n = 4, N = 51; GFP 0.9760.15, n = 4, N= 60; sh-
Smn 0.0860.02, n = 4, N = 74; P,0.01, t = 4.929) were significantly reduced in comparison to uninfected cells. (C) Subcellular distribution of hnRNP R
in soma, axon and growth cone of primary motoneurons cultured for 5DIV and costained against synaptophysin (SynPhys) and neurofilament (NF-L)
(scale bar: 10 mm (upper row), 5 mm). (D) Lentiviral knockdown of hnRNP R led to a dose-dependent reduction of hnRNP R levels. Calnexin and Smn
protein were not altered significantly. (E) HnRNP R knockdown was also detected by immunofluorescence validating the used antiserum peptide ICN
1-18 (GFP 1.0060.04, n = 8, N= 100; sh-hnRNP R 0.4860.04, n = 6, N= 63; P,0.0001, t = 8.719, DF = 12) (scale bar: 10 mm).
doi:10.1371/journal.pone.0110846.g001
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cence in isolated embryonic motoneurons (see Fig. 2) and Western
blot analyses of coimmunoprecipitation from cytosolic fractions
(see Fig. 3).
In order to address whether Smn and hnRNP R are also present
in axon terminals in vivo we examined neuromuscular endplates
in the Diaphragm from 18-day old mouse embryos (Fig. 5B).
Motor endplates in whole mount preparations of the Diaphragm
were identified by v-bungarotoxin (BTX) staining of postsynaptic
acetylcholine receptors. At this site, Smn- and hnRNP R-positive
signals were detected with partially colocalizing points (PCC
0.2460.04; MOC 0.5460.02; N= 6).
To characterize the localization of Smn and hnRNP R at
neuromuscular junctions in more detail, confocal microscopy at
different developmental stages was performed with synaptophysin
(SynPhys) as a marker for presynaptic terminals (Fig. 6). Postsyn-
aptic nuclei were visualized by DAPI staining. At E18, Smn was
strongly enriched in presynaptic compartments (Fig. 6A, left
panel). Smn-positive signals were also detected in presynaptic
terminals at postnatal day 4 (Fig. 6A, middle panel, 6B, Fig. S2A)
and in the adult (Fig. 6A, right panel). However, levels of Smn
immunoreactivity were lower at the latter stage, which corre-
sponds to decreased Smn expression in spinal cord of adult mice
[53]. At these analyzed neuromuscular junctions postsynaptic
nuclei and the postsynaptic space labeled by BTX contained few
Smn-positive signals at any developmental stage which confirms
muscular expression and localization [54–58]. We also performed
cryostat sections of ventral roots of the gastrocnemic muscle of
adult mice and observed both Smn- and hnRNP R-positive signals
in motor axons of sciatic nerves at this stage in vivo (Fig. S2C).
HnRNP R protein was mainly colocalized with synaptophysin
in presynaptic terminals in the Diaphragm at E18 (Fig. 6C, left
panel). In addition, hnRNP R was detected in postsynaptic
structures. Similar findings were obtained at P4 (Fig. 6C, middle
panel, 6D, Fig. S2B) and in the adult (Fig. 6C, right panel). In the
adult, hnRNP R immunoreactivity appeared reduced in presyn-
aptic terminals reflecting decreased hnRNP R expression in
motoneurons during postnatal development [18]. As a control,
preabsorption with recombinant hnRNP R highly depleted
Figure 2. Colocalization of Smn and hnRNP R proteins in embryonic motoneurons. Representative images of cell bodies, axons and
growth cones of primary embryonic motoneurons cultured on laminin-111 (A) and laminin-221/211 (B) for 5DIV and stained against Smn and hnRNP
R (scale bar: 5 mm). Superimposed colocalizing points are highlighted in white. (C) No differences were observed with respect to colocalization and
subcellular distribution of hnRNP R between these two investigated laminin isoforms. Representative images of cell bodies, axons and growth cones
of motoneurons cultured on laminin-111 for either 3DIV (D) or 7DIV (E) and labeled against Smn and hnRNP R (scale bar: 5 mm). Both the degree of
overlap between Smn and hnRNP R and the subcellular distribution of hnRNP R were regulated over time. The relative ratio of cytosolic versus
nuclear hnRNP R immunoreactivity was significantly enhanced by 63% (P= 0.0173, t = 3.914, DF= 4) in motoneuron cell bodies cultured for 7DIV
(1.6360.16, n = 5, N= 46) in comparison to 3DIV (set as ‘1’; n = 5, N= 37). (F) After 7DIV (PCC 0.6560.02, MOC 0.7560.01, n = 5, N= 45) colocalization of
Smn and hnRNP R in motoneuron cell bodies was higher (PCC P=0.0112, t = 4.453, DF = 4; MOC P= 0.0086, t = 4.807, DF= 4) than after 3DIV (PCC
0.5660.03, MOC 0.6860.02, n = 5, N = 36). In axons the degree of overlap and correlation did not change (PCC P=0.1504, t = 1.776, DF= 4; MOC
P= 0.1449, t = 1.808, DF= 4) over time (3DIV PCC 0.4360.04, MOC 0.5560.03, n = 5, N= 36; 7DIV PCC 0.4660.04, MOC 0.5860.03, n = 5, N= 46),
whereas in axonal growth cones a significant modification of the correlation (PCC P= 0.0467, t = 2.844, DF= 4; MOC P= 0.1565, t = 1.742, DF= 4) of
both proteins was detected (3DIV PCC 0.3860.03, MOC 0.5260.02, n = 5, N= 37; 7DIV PCC 0.4560.02, MOC 0.5660.02, n = 5, N= 34).
doi:10.1371/journal.pone.0110846.g002
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Figure 3. Direct interaction of hnRNP R and SMN. (A) Purification scheme of recombinant hnRNP R and SMN expressed as His-tagged proteins
in E. coli strain BL21. (B) Affinity purification profile on a fast protein liquid chromatography (FPLC) of hnRNP R and SDS-PAGE of recombinant hnRNP
R purification steps visualized by silver staining. (C) Affinity purification profile on a FPLC of SMN and SDS-PAGE of recombinant SMN purification
steps visualized by colloidal staining. (D) Coimmunoprecipitation of recombinant SMN and hnRNP R.
doi:10.1371/journal.pone.0110846.g003
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Figure 4. Coimmunoprecipitation of Smn and hnRNP R in primary motoneurons and native spinal cord. (A) 1 000 000 primary
motoneurons were cultured for 7DIV on laminin-111. Cytosolic and soluble nuclear fractions were subjected to a pull-down with either Smn or hnRNP
R antibodies, respectively. Coprecipitation of hnRNP R or Smn, respectively, was determined revealing an interaction of Smn and hnRNP R, particularly
in the cytosolic fraction of embryonic mouse motoneurons (eluate lane). Smn was not detectable in the soluble nuclear fraction of motoneurons.
Localization of Smn and hnRNP R in Motor Axon Terminals
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hnRNP R immunoreactivity implying that the signals detected by
ICN 1-18 were also specific in vivo (Fig. S3).
Reduced Smn immunoreactivity at neuromuscular
junctions of a SMA type I mouse model
To validate the specificity of the observed presynaptic Smn
staining in vivo, whole mount preparations from three E18 Smn2/
2; SMN2tg mouse Diaphragms were analyzed and compared
with controls (Fig. 7), revealing a significant reduction of the mean
Smn signal intensity of 57% in SMA type I NMJs (0.4360.09,
P = 0.0220, n = 3, N= 32) in comparison to control samples (n = 3,
N= 43), whereas neither the size of the presynaptic compartment
nor SynPhys signal intensities were significantly altered at this
developmental stage (Fig. 7A, B). We also investigated cytosolic
Smn immunoreactivity in the corresponding E18 Smn2/2;
SMN2tg (n = 6, N= 85) motoneuron cell bodies in spinal cord
cross sections, detecting a significant decrease of 54% (0.4660.05,
P,0.0001) in comparison to Smn+/+; SMN2tg cells (n = 6,
N= 107) (Fig. 7C). These two results were at variance with
previous studies reporting profound loss of Smn protein in the
range of 80% in brain extracts from these mice [59]. Therefore,
we analyzed cytosolic and nuclear fractions from four E18 SMA
type I spinal cords and corresponding control tissue in order to
obtain more robust biochemical data and to validate the
aforementioned immunohistochemical quantitative analysis
(Fig. 7D). Smn protein levels were significantly reduced by 86%
(0.1460.03, n = 10, P,0.0001) in nuclear and by 64%
(0.3660.08, n= 10, P,0.0001) in cytosolic fractions of Smn2/2;
SMN2tg spinal cord, respectively. With respect to the underlying
biological variances derived from independent embryos and litters
in vivo we concluded from these data that the differences
determined by immunohistochemistry were in line with the
reduction of cytosolic Smn protein quantified by biochemical
HnRNP R was found both in nuclear and cytosolic extracts. For immunoprecipitation experiments a C-terminal antibody directed against hnRNP R
(Abcam) was used [29]. Supernatants still contained some Smn or hnRNP R protein, respectively, suggesting that the interaction appears not to be
exclusive as demonstrated by immunofluorescence colocalization analysis. No signal was obtained in the washing solution. Successful fractionation
was controlled by a tubulin (cytosol) and histone H3 (nucleus) (right panel). (B) Fractionation of spinal cord tissue from E18 mouse embryos revealed
a similar result as shown in (A). In the cytosolic fraction hnRNP R IP pulled-down Smn protein and vice versa. Nuclear Smn was not detected in the
soluble, but in the corresponding insoluble nuclear fraction (right panel, lower blot). In contrast, nuclear hnRNP R was not found in the insoluble
nuclear fraction. Cytosolic and nuclear extracts were validated by a tubulin and histone H3. (C) HEK293T cells were cultured and cytosolic and soluble
nuclear fractions were prepared. Smn and hnRNP R were detected in cytosolic extracts as well as in soluble nuclear fractions. The pull down of Smn
and hnRNP R, respectively, was successful (eluate lane, IP), but hnRNP R or Smn, respectively, could not be coprecipitated, neither from cytosolic nor
from nuclear extracts. Successful fractionation was verified by GAPDH (cytosolic) and histone H3 (nucleus) (right panel).
doi:10.1371/journal.pone.0110846.g004
Figure 5. Colocalization of Smn and hnRNP R in vivo in E18 motoneurons and axon terminals. (A) Representative cross section from E18
spinal cord stained against Smn, hnRNP R and ChAT (scale bar: 10 mm). Superimposed colocalizing points are highlighted in white. Smn signals were
mainly found in the cytosol, with very few positive spots in the nuclei. HnRNP R immunoreactivity was observed in the nucleus and in the cytosol.
Colocalization of Smn and hnRNP R was detected in the cytosol, especially in axonal initiation segments (PCC 0.2760.03, MOC 0.8160.01, N= 8). (B)
Whole mount preparations from Diaphragmmuscles from E18 mouse embryos stained against Smn, hnRNP R, v-BTX and DAPI (scale bar: 2 mm). Both
Smn and hnRNP R immunoreactivity were detected at these defined sites showing partial overlap (PCC 0.2460.04, MOC 0.5460.02, N = 6).
doi:10.1371/journal.pone.0110846.g005
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analysis, thus confirming the specificity of the applied Smn
antibody also in vivo.
Discussion
Since the discovery of SMN mutations as cause of SMA
multiple efforts have been made in elucidating the role of the
corresponding protein particularly in motoneuron development
and maintenance. Whilst SMN has a central cellular role in the
assembly of spliceosomal snRNPs (reviewed in [38]) it is now
becoming increasingly clear that SMN also interacts with a
number of RNA-binding proteins such as FMRP [30], KSRP
[60], hnRNP R and Q [18,19], TDP-43 [61], FUS [31], IMP1
[62] and HuD [36,63,64]. In this study we provide evidence that
Smn colocalizes and interacts with hnRNP R in distinct
subcellular compartments of motoneurons. Beside the already
known location in nucleus and cytosol both proteins are present in
axon terminals in vivo at embryonic and postnatal stages
providing additional weight to the hypothesis that Smn, together
with hnRNP R and possibly also other mRNA-binding proteins,
contributes significantly to maturation and function of neuromus-
cular synapses by direct local action in the presynaptic compart-
ment [4,8,12–14].
HnRNP R has been identified as an interaction partner of Smn
[18]. Furthermore, hnRNP R binds to U-rich sequences within the
39UTR of b-actin mRNA [19,29] and participates in the
translocation of this mRNA into axons and axon terminals [19].
Accordingly, loss of either Smn or hnRNP R reduces axon growth
of isolated mouse motoneurons [19,29]. Smn-deficient motoneu-
rons exhibit defects in the actin cytoskeleton in axonal growth
cones resulting in impaired maturation and differentiation of these
specialized structures to presynaptic terminals at neuromuscular
endplates [15,19,65]. This correlates with defective translocation
of Cav2.2 calcium channels and eventually other transmembrane
proteins to the surface, preventing calcium influx and the
recognition of essential differentiation signals provided by direct
interaction of Cav a subunits and b2 laminin chains [15,46,66]. In
line with these observations, depletion of Smn or hnRNP R in
zebra fish leads to comparable phenotypes with respect to
truncated motor axons and aberrant branching in peripheral
regions pointing to a common functional pathway also in vivo
[29,37].
Figure 6. Localization of Smn and hnRNP R at neuromuscular junctions from E18, P4 and adult Diaphragm. Whole mount preparations
from Diaphragm muscles from developmental (E18) (A, C, left panels), postnatal (P4) (A, C, middle panels) and adult (3 months) (A, C, right panels)
stages were performed (scale bar: 2 mm (C, left panel), 5 mm). (A) Muscles were stained against v-BTX, SynPhys, DAPI and Smn protein. (A, left panel)
At E18 Smn was highly enriched in presynaptic structures identified by SynPhys immunoreactivity. Few spots appeared in postsynaptic nuclei. (A,
middle panel) Smn-positive signals were also detected in P4 motor endplates coresiding with SynPhys staining. Postsynaptic nuclei showed faint Smn
immunoreactivity. (A, right panel) In 3 month old mice (adult stage) less Smn-positive signals were noticed as described before [53,56]. The few
immunoreactive particles were predominantly located in presynaptic structures visualized by SynPhys staining. (B) Single optical slices of the P4
neuromuscular synapse highlighted the co-occurring SynPhys and Smn signals (scale bar: 5 mm). (C) Muscles were stained against v-BTX, SynPhys,
DAPI and hnRNP R. HnRNP R was codistributed with SynPhys in presynaptic compartments at E18 (left panel), P4 (middle panel) and adult stage (right
panel). HnRNP R was also detected in postsynaptic structures revealing stronger immunoreactivity at these sites in comparison to Smn. (D) Single
optical slices of the P4 motor endplate emphasized the presynaptic localization of hnRNP R (scale bar: 5 mm).
doi:10.1371/journal.pone.0110846.g006
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Figure 7. Smn deficiency in SMA type I axon terminals in vivo. (A, B) Representative motor endplates from E18 Smn+/+; SMN2tg and Smn2/2;
SMN2tg Diaphragm stained against Smn and SynPhys. Acetylcholine receptors (AChR) and postsynaptic nuclei were visualized by v-BTX and DAPI,
respectively (scale bar: 5 mm). In (A) Smn deficiency is visible by highly reduced immunoreactive signals, as highlighted in the white box, whereas in
(B) the number of Smn particles per NMJ is decreased in SMA type I motor endplates, as indicated by white arrowheads. (A, B) In SMA type I axon
terminals (n = 3, N = 32) mean Smn signal intensity was significantly reduced (0.4360.09, P = 0.0220, t = 6.629, DF= 2) in comparison to control motor
endplates (set as ‘1’, n = 3, N= 43), whereas SynPhys signals (Smn2/2; SMN2tg 1.1560.19, P = 0.5221, t = 0.7694, DF= 2) and the size of the presynaptic
compartment (Control 49.48613.94 mm2; Smn2/2; SMN2tg 36.5667.464; P = 0.4596, t = 0.8174, DF= 4) were comparable. (C) Representative images
from E18 Smn+/+; SMN2tg and Smn2/2; SMN2tg spinal cord cross sections immunolabeled with Smn and ChAT. Quantitative analysis revealed a
significant decrease in cytosolic Smn immunoreactivity in SMA type I motoneurons in comparison to Smn+/+; SMN2tg cells (Smn+/+; SMN2tg set as ‘1’,
n = 6, N= 107; Smn2/2; SMN2tg 0.4660.05, n = 6, N= 85; P,0.0001, t = 11.23, DF= 5). ChAT signal intensity was not statistically affected (Smn2/2;
SMN2tg 0.8360.21; P = 0.4638, t = 0.7928, DF= 5). (D) Representative Western Blot with cytosolic and nuclear fractions from E18 control and Smn2/2;
SMN2tg spinal cord extracts. Histone H3 and a tubulin were used as markers for nuclear and cytosolic fractions, respectively, and as standardization
proteins for quantitative analysis. In SMA type I spinal cord extracts cytosolic and nuclear Smn were significantly reduced by 64% (0.3660.08, N = 10,
P,0.0001, t = 8.480, DF= 9) and 86% (0.1460.03, N = 10, P,0.0001, t = 26.39, DF= 9), respectively, in comparison to Smn+/+; SMN2tg extracts (set as ‘1’,
N = 10).
doi:10.1371/journal.pone.0110846.g007
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Recently, Smn has been visualized in spinal motoneuron cell
bodies in vivo [8,32,67,68], whereas its presence in the presyn-
aptic compartment of neuromuscular junctions, particularly of
postnatal mice, at least to our knowledge, has not been reported
yet. Previous attempts to detect SMN in these structures have
rather revealed a codistribution with postsynaptic marker BTX
than with presynaptic markers SynPhys or neurofilament (NF) [7].
Notably, Smn immunoreactivity has also been detected in skeletal
muscle [56,57], which complicates reliable visualization of
presynaptic Smn. In this study we chose the Diaphragm to
perform immunohistochemistry at neuromuscular synapses to
ensure controlled orientation due to the defined anatomy of the
Diaphragm. Furthermore, we applied IgG1 mouse antibodies for
immunodetection reducing the probability of false-positive signals
derived from unspecific binding of the applied mouse monoclonal
SMN antibody to endogenous mouse IgG antibodies and
homologous adhesion molecules. Smn expression is known to
decrease in motoneurons at later postnatal stages, which makes it
difficult to detect Smn protein in sections of spinal cord, motor
nerves and at neuromuscular endplates [53]. Nevertheless, we
were able to visualize Smn in presynaptic motor nerve terminals
particularly of E18 and P4 neuromuscular junctions in addition to
the already reported postsynaptic intramuscular localization
[7,56,57].
Smn and hnRNP R are partially colocalizing in axons and axon
terminals and also in the perinuclear region within the soma of
motoneurons. Since both hnRNP R and Smn have numerous
interaction partners with various functions, this spatial distribution
and correlation is not surprising and indicates that dynamic
interactions of Smn, hnRNP R and other RNA binding proteins
could take place in axons and axonal compartments which need to
be investigated in more detail. This hypothesis is supported by the
observation that the axonal and presynaptic colocalization of
hnRNP R with Smn changes over time. The highest degree of
overlap is observed when axon elongation and presynaptic
differentiation occur [15]. This dynamic change in codistribution
and the relatively high levels of these proteins in cytosolic
structures during this period could correspond to the in vitro
deficits in axon growth observed in Smn- [15,19] and hnRNP R-
deficient [29] motoneurons. In order to corroborate this result,
coimmunoprecipitation experiments were performed with recom-
binant and purified Smn and hnRNP R, and also with isolated
motoneurons, spinal cord extracts and non-neuronal cells. These
experiments revealed a direct interaction of hnRNP R and Smn
predominantly in the cytosol of motoneurons. In HEK293T cells,
Smn and hnRNP R could not be coimmunoprecipiated, neither
from nuclear nor from cytosolic extracts thus pointing to
differences between neuronal and other cell populations.
Recently, it has been demonstrated that mutant FUS sequesters
axonal Smn [69], disturbs snRNP localization [70], reduces the
number of Gems [71] and develops synaptic defects at neuromus-
cular junctions [72,73], thus establishing a potential correlation
between ALS and SMA [74]. Similar results were reported for
TDP-43 [33]. Mutant TDP-43 reveals impaired transport of
cytoplasmic mRNP granules [75]. Notably, axonal transport
deficits have also been identified in SMND7 mice [76]. In our
study, shRNA-mediated hnRNP R depletion did not interfere with
Smn expression or the number of Gems per nucleus. Equally, Smn
depletion did not alter hnRNP R protein levels in motoneurons,
indicating that these two proteins are not major regulators of each
other at the levels of transcription and early pre-mRNA
processing. This appears different with other members of the
hnRNP family that control Smn levels at the pre-mRNA
processing stage [77–83]. Thus, cytosolic hnRNP R that is bound
to Smn could exert unique functions in comparison to nuclear
hnRNP R and other members of the hnRNP family.
Nuclear and perinuclear Smn could also affect the assembly and
axonal transport of protein/RNA-containing particles, and this
process could potentially contribute to SMA pathology. Recent
data have shown that Smn mediates the axonal localization of
IMP-1 [62] and the trafficking of cpg15 mRNA via binding to
HuD [64], additionally regulating local translation [63,84]. In line
with these findings are reports stating that mutant hnRNP A2B1
and A1 are incorporated into stress granules resulting in aberrant
cytoplasmic inclusions, which possibly impairs their axonal
function [85]. Furthermore, more than 200 mRNAs associated
with SMN have been identified in differentiated NSC-34 cells with
30% revealing an SMN-dependent axonal localization [86]. Using
RNA-seq techniques, cell-specific mRNA transcriptome changes
have been described that affect NMJ formation and maintenance
[87] and it appears logical that these alterations can be assigned to
axonal and/or somatodendritic compartments. Taken together, a
similar functional relationship of Smn and hnRNP R, i.e. a Smn-
dependent axonal translocation of hnRNP R and hnRNP R-
bound mRNAs, may therefore be a legitimate assumption.
Conclusion
Biochemical and immunohistochemical analyses performed in
this study provide evidence of a direct interaction of Smn and
hnRNP R in spinal motoneurons in vitro and in vivo, predom-
inantly in the cytosolic compartment. Both proteins are present in
axons and axon terminals of motoneurons in vitro and in vivo.
We hypothesize that axonal and presynaptic Smn and hnRNP R
proteins are not involved in U snRNP assembly, but exert a non-
canonical function which contributes to differentiation and
maintenance of neuromuscular endplates.
Materials and Methods
Animals and ethics statement
C57Bl/6, CD-1 and SMA type I transgenic mice [59] were kept
at the animal facilities of the Institute for Clinical Neurobiology at
the University hospital of Wuerzburg providing controlled
conditions such as food and water in abundant supply, 20–22uC,
a 12 hours light/dark cycle, and 55–65% humidity, respectively.
Each experiment was performed strictly following the regulations
on animal protection of the German federal law, the Association
for Assessment and Accreditation of Laboratory Animal Care and
of the University of Wuerzburg, in agreement with and under
control of the local veterinary authority and Committee on the
Ethics of Animal Experiments, i.e. Regierung von Unterfranken,
Wuerzburg (License numbers 566/200-244/13 and 55.2-2531.01-
08/14).
This study was approved by the local veterinary authority
(Veterinaeramt der Stadt Wuerzburg) and Committee on the
Ethics of Animal Experiments, i.e. Regierung von Unterfranken,
Wuerzburg (License numbers 566/200-244/13 and 55.2-2531.01-
08/14).
Isolation and culture of primary embryonic mouse
motoneurons
Spinal cord tissue from E13.5 mouse embryos was isolated and
motoneurons were enriched via p75-panning as described
previously [88]. In brief, lumbar spinal cord was dissected and
processed thoroughly by removing dorsal root ganglia (DRGs) and
meninges. After digestion with 0.1% trypsin (Worthington)
motoneurons were enriched by incubation with anti-p75 anti-
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body-coated (MLR2, Abcam) cell culture dishes. Cells were
counted and plated on cell culture dishes or glass cover slips which
had been coated with laminin-111 or laminin-221/211, respec-
tively. Motoneurons were cultured in the presence of 10 ng/ml
BDNF and CNTF for 5DIV or 7DIV, respectively, at 37uC in a
5% CO2 atmosphere. Motoneuron medium, comprising Neuro-
basal Medium (Gibco), 2% horse serum, 500 mM GlutaMAX-I
(Gibco) and B27 (1:50, Gibco), was changed at 1DIV and then
every second day.
Lentiviral knockdown experiments were performed by incuba-
tion of motoneuron directly before plating with either control or
knockdown viruses, respectively, for 8 min at RT. Infected cells
were identified by GFP reporter expression from lentiviral
constructs.
Immunocytochemical analysis of embryonic mouse
motoneurons
Cells were washed with warm PBS (PAA Laboratories, pH 7.4)
to remove serum and debris, and fixed with 4% paraformaldehyde
(PFA) for 15 min at RT. Treatment with 0.3% TritonX for
20 min at RT ensured decent antibody penetration of the nuclei.
Unspecific binding of antibodies was reduced to a minimum by
blocking with either 10% BSA or serum of the species of the
secondary antibody, i.e. goat or donkey serum, respectively.
Primary antibodies were applied overnight at 4uC. Cells were
washed thoroughly and incubated with appropriate fluorescent
secondary antibodies. Nuclei were counterstained with DAPI.
Coverslips were embedded with Mowiol (Sigma-Aldrich, 10852)
and imaged subsequently.
The following primary and secondary antibodies were used in
this study: monoclonal mouse anti-SMN (1:250, BD Biosciences,
610646), polyclonal rabbit anti-hnRNP R (1:250, Sigma
HPA026092; 1:2000, polypeptide antiserum aa1-18, ICN, Wuerz-
burg), polyclonal guinea pig anti-Synaptophysin (1:600, Synaptic
Systems), polyclonal chicken anti-Neurofilament (heavy chain)
(1:5000, Millipore AB5539), goat anti-mouse (H+L) IgG1 (Cy5,
1:500, Abcam ab136127), donkey anti-rabbit (H+L) IgG (Cy3,
1:700, Jackson Immunoresearch 711-165-152), donkey anti-guinea
pig (H+L) IgG (Cy2, 1:400; Dianova 706-225-148) and donkey
anti-chicken (H+L) IgG (DyLight 649, 1:500, Jackson Immunor-
esearch 703-495-155).
Knockdown of Smn and hnRNP R via lentiviral shRNA in
embryonic motoneurons
Viruses were produced according to the manufacturer’s
instructions expressing either shRNA against Smn or hnRNP R,
respectively, or a GFP-reporter gene as internal control. The
knockdown vector for hnRNP R and Smn was generated by
cloning hnRNP R (59-GATGCTCTCAGGGAGTTTAAT-39)
and Smn (59-GAAGAATGCCACAACTCCC-39) shRNA se-
quence into the pSIH-H1 shRNA vector (System Bioscience).
HEK293T cells were used to generate viruses as described
previously [89,90].
Data analyses and statistics
At least three independent experiments were performed for
statistical analysis. Data are expressed as mean6 standard error of
the mean (SEM). ‘N’ indicates the total number of analyzed
specimens, e.g. NMJs, axons, growth cones or motoneuron cell
bodies, and ‘n’ the number of individual specimens, e.g. different
embryos from different litters, different wells from independent
cultures or different object slides and technical Western Blot
replicates from different embryos, which were statistically scored.
For comparison of two groups unpaired (Fig. 1E, Fig. 7A, B) or
paired (Fig. 2, Fig. S1C) student’s t-test, or one sample t-test
(Fig. 2C, D, Fig. 7A–D, Fig. S1C) was used, respectively. For
comparison of three groups (Fig. 1B) ‘Repeated Measures
ANOVA’ with post-hoc Bonferroni multiple comparison was
applied.
For statistical analyses the GraphPad Prism 4.02 software
(SanDiego, CA) was used. Fluorescence intensities were measured
as mean gray values per stained area and displayed as arbitrary
units, based on quantum levels (QL) per pixel, using the Leica LAS
AF LITE Software. Signal intensities were determined from raw
images for each optical slice by subtracting background intensities
from the measured immunoreactive signals. To determine the
relative Smn fluorescence intensity of motor endplates, average
intensity stacks were created from confocal data sets, and the mean
signal intensity of all Smn particles of one analyzed neuromuscular
junction was scored. For calculating the ratio between cytosolic
and nuclear compartments the sizes of the determined regions of
interests were taken into account. Values of consistent control
groups and relative values of control groups were standardized to
‘1’ and data from different experiments were combined when
control values were comparable to each other.
Image acquisition and processing
For image acquisition the Leica TCS SP2 and SP5 confocal
systems were used, as well as the Olympus Fluo ViewTM FV1000
microscope. For intensity measurement identical settings were
applied, i.e. objective, magnification, laser intensity and photo-
multiplier. Final processing of all images was performed with
Image-J (MacBiophotonics), Photoshop 7.0 (Adobe) and Illustrator
CS5 (Adobe). The average intensity stack function was used in
figure 1B, E, and S1C, and the maximum intensity stack function
in figure 1C (upper panel, i.e. cell body), 5B, 6A, C (middle and
right panel), 7A, B, S2A–C and S3A, B. In figure 6 and figure
S2A, B postsynaptic motor endplate staining by BTX was
smoothened for better visualization.
Brightness and contrast were enhanced in the following images
for better visualization:
Figure 6A (8bit) (left panel): BTX (MIN20), DAPI (MIN10),
SynPhys (MIN20), Smn (MIN10)
Figure 6A (8bit) (middle panel): BTX (MIN30), DAPI
(MIN20), SynPhys (MIN20), Smn (MIN20)
Figure 6A (8bit) (right panel): BTX (MIN20, MAX175),
DAPI (MIN20), SynPhys (MIN10 MAX150), Smn (MIN10)
Figure 6C (8bit) (left panel): BTX (MIN20), SynPhys
(MIN20), hnRNP R (MIN20)
Figure 6C (12bit) (middle panel): BTX (MIN200
MAX2500), DAPI (MIN200), SynPhys (MIN400), hnRNP R
(MIN350)
Figure 6C (8bit) (right panel): BTX (MIN20), DAPI
(MIN20), SynPhys (MIN20), hnRNP R (MIN25)
Figure 7A, B (8bit): BTX (MIN20), DAPI (MIN10), SynPhys
(MIN5), Smn (MIN20)
Figure 7C (12bit): ChAT (MIN200 MAX 3500), Smn (MIN200
MAX 2000)
Figure S3A, B (8bit): BTX (MIN10), DAPI (MIN10), SynPhys
(MIN10), hnRNP R (MIN20)
Colocalization analysis
Colocalization was analyzed using the Pearson’s correlation
coefficient (PCC) and the Manders Overlap Coefficient (MOC)
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plugin of ImageJ. MOC measures the percentage of overlap of two
signals computationally standardizing size and intensity and
excluding ‘zero’ pixels. Thus, co-occurrence of individual fluor-
ophores is determined. Perfectly colocalizing points within the
spatial resolution of the used objective, magnification and
microscope are rated ‘1’. In contrast, PCC is applied to quantify
the correlation between individual fluorophores taking their
intensities into consideration. To exclude a ‘random colocaliza-
tion’ of Smn and hnRNP R we used ImageJ for a colocalization
test with Fay randomization which compares and validates the
PCC of the ‘real’ image against 25 ‘randomly created’ images
generated by repeatedly shifting pixels of one of the color
channels:
Figure 2A, C (5DIV, Laminin): Cell body (PCCreal = 0.59,
PCCrandom = 0.55), axon (PCCreal = 0.42, PCCrandom = 0.22),
growth cone (PCCreal = 0.39, PCCrandom= 0.25)
Figure 2B, C (5DIV, Laminin-221/211): Cell body
(PCCreal = 0.53, PCCrandom= 0.50), axon (PCCreal = 0.35, PCCran-
dom= 0.20), growth cone (PCCreal = 0.31, PCCrandom= 0.20)
Figure S1D (N-terminal hnRNP R antibody from Sigma):
Cel l body (PCCrea l = 0.66, PCCrandom = 0.56) , axon
(PCCreal = 0.26, PCCrandom= 0.19), growth cone (PCCreal = 0.26,
PCCrandom= 0.19)
For better visualization the ‘Colocalization Finder’ plugin of
ImageJ was applied highlighting artificially superimposed coloca-
lizing points calculated computationally.
Immunohistochemial analysis of motor endplates
The Diaphragm muscle was dissected from E18, P4 or adult
mice by carefully cutting alongside the ribs and thoroughly
removing attached liver and lung tissue. The tissue was washed in
PBS-T (0.1% Tween-20) for 20 min at RT. Blood clots and fasciae
were carefully purged off the muscle tissue prior to fixation with
4% PFA at RT for 12 min (E18), 15 min (P4) or 20 min (adult
stage), respectively. After incubation with v-Bungarotoxin (Invi-
trogen, conjugated with Alexa488 or Alexa647, respectively) for
25 min at RT, the Diaphragm was incubated overnight at 4uC
with a blocking solution comprising 2% BSA, 0.1% Tween-20 and
10% donkey serum or 15% goat serum, respectively. The tissue
was then incubated with primary antibodies for three days at 4uC.
After washing with PBS (pH 7.4, PAA Laboratories) thrice for
15 min each appropriate secondary antibodies were applied for
1 h at RT. Again, the tissue was washed three times with PBS for
each 15 min, counterstained with DAPI and embedded in Aqua
Polymount (Polysciences). For immunohistochemical analysis the
following primary and secondary antibodies were used: monoclo-
nal mouse anti-SMN (1:250, BD Biosciences, 610646), polyclonal
rabbit anti-hnRNP R (1:2000, polypeptide antiserum aa1-18,
ICN, Wuerzburg), polyclonal guinea pig anti-synaptophysin
(1:600, Synaptic Systems), goat anti-mouse (H+L) IgG1 (Cy5,
1:500, Abcam ab136127), donkey anti-rabbit (H+L) IgG (Cy3,
1:700, Jackson Immunoresearch 711-165-152), donkey anti-guinea
pig (H+L) IgG (Cy2, 1:400; Dianova 706-225-148 or Cy3, 1:500;
Dianova 706-166-148). Notably, a mouse monoclonal IgG1
antibody was used for immunodetection of Smn reducing
unspecific signals derived from endogenous mouse antibodies
and adhesion molecules which share great homology with
immunoglobulins. For visualization of presynaptic hnRNP R or
Smn, respectively, ‘planar’ endplates with prominent SynPhys
staining and nuclei barely touching the BTX- and SynPhys-
positive area were preferably imaged. For P4 and adult tissue the
Diaphragm muscle was teased directly after fixation to improve
antibody penetration.
Immunohistochemical analysis of cross sections from
native embryonic spinal cords
Spinal cords were isolated without vertebrae from E18 mouse
embryos. Tissues were washed with PBS for 20 min at RT prior to
fixation with 4% PFA for at least 2 h at RT. Spinal cords were
kept in 30% sucrose solution overnight at 4uC. Spinal cords were
embedded in Tissue Tek (O.C.T. Mount Medium, Sakura) and
10 mm thick cross cryosections were produced. Cross sections were
washed with PBS and blocked with 10% donkey serum, 2% BSA
and 0.3% TritonX for 1 h at RT. Then, primary antibodies
against ChAT (anti-ChAT, 1:100, Millipore, AB144P), Smn (anti-
SMN, 1:250, BD Biosciences, 610646) and hnRNP R (anti-
hnRNP R polypeptide antiserum aa1-18, 1:2000, ICN, Wuerz-
burg) were added overnight at 4uC. Cross sections were washed
with PBS thrice and secondary antibodies (donkey anti-rabbit (H+
L) IgG conjugated with Cy3, 1:700, Jackson Immunoresearch
711-165-152; donkey anti-mouse (H+L) IgG conjugated with
Alexa488, 1:400, Invitrogen A-21202); donkey anti-goat (H+
L) IgG conjugated with Cy5, 1:300, Jackson Immunoresearch
705-175-003) were applied for 1 h at RT. After washing with PBS
for three times cross sections were embedded in Aqua Polymount
(Polysciences).
Preparation and staining of cryostat sections of ventral
roots and sciatic nerves
The Gastrocnemius was prepared as described previously [91].
Briefly, adult mice were perfused with 4% PFA and ventral roots
were isolated, postfixed in 4% PFA overnight and transferred into
buffer with increasing sucrose content, i.e. 10 to 30%. Afterwards,
the tissue was embedded in Tissue Tek (O.C.T. Mount Medium,
Sakura) and frozen within 2-methylbutane cooled by liquid N2.
The ventral roots were cut in 10 mm thick cross cryosections. The
sections were then stained as described above. The following
primary and secondary antibodies were used: Smn (anti-SMN,
1:250, BD Biosciences, 610646), hnRNP R (anti-hnRNP R
polypeptide antiserum aa1-18, 1:2000, ICN, Wuerzburg) and
neurofilament (anti-neurofilament, 1:500, AB5539, Millipore),
goat anti-mouse (H+L) IgG conjugated with Cy3 (1:200, Jackson
Immunoresearch 115-165-003), swine anti-rabbit (H+L) IgG
conjugated with FITC (1:40, Dako, F0205) and goat anti-chicken
(H+L) IgG conjugated with Cy5 (1:400, ab6569, Abcam).
Purification of murine recombinant hnRNP R and SMN
protein
His-tagged hnRNP R and SMN full length proteins were
expressed in E. coli after cloning the corresponding cDNA
constructs into the pET-28a and pET-32a vector system
(Novagen, Madison, WI), respectively. The expected molecular
size of the His-Tag from this vector corresponds to 15 kDa. In line
with this notion, the molecular sizes of the tagged proteins are
89.1 kDa for recombinant hnRNP R and 49.8 kDa for recombi-
nant SMN. Both proteins were purified using 1 ml His-Trap HP
and Superdex 10/300 gel filtration columns (GE Healthcare). The
recombinant proteins were produced in the E. coli strain BL21
grown in MagicMedium (Invitrogen) for 6 hours at 30uC and for
18 hours at 18uC without further induction. Bacterial pellets were
sonicated for 1–2 min in 50 mM sodium phosphate (pH 8.0),
500 mM NaCl, 20 mM imidazole, 5% (v/v) glycerol, 1 mM
TCEP and protease inhibitor (Roche), and spinned for 30 min at
30 000 g. The clarified supernatants were loaded onto a 1 ml His-
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Trap HP column at 0.5 ml/min flow rate. The columns were
washed for several hours with 50 mM sodium phosphate buffer
(pH 8.0), 500 mM NaCl, 30 mM imidazole, 5% (v/v) glycerol and
0.5 mM TCEP at a flow rate of 1.0 ml/min. Bound proteins were
eluted with 50 mM sodium phosphate buffer (pH 8.0), 500 mM
NaCl, 250 mM imidazole, 5% (v/v) glycerol and 0.5 mM TCEP
at a flow rate of 1.0 ml/min. In a final step eluted proteins were
subjected to a size exclusion column using a Superdex 10/300
column that was run with 50 mM sodium phosphate buffer
(pH 8.0), 50 mM NaCl and 5% (v/v) glycerol at a flow rate of
0.5 ml/min. Fractions and purified proteins were separated on 8%
PAA gels and colloidial or silver stained. Whole purification was
conducted on an A¨ckta FPLC system (GE Healthcare). To
determine protein concentration spectrophotometric measure-
ments were carried out with a Nanodrop (ND-1000, PeqLab).
Image processing of colloidial stainings was carried out with
Photoshop 7.0 (Adobe).
Subcellular fractionation of mouse motoneurons
At least 100 000 primary motoneurons were plated on a 12-well
cell culture dish and cultured for 7DIV in the presence of 10 ng/
ml BDNF and CNTF. Buffers for fractionation were prepared
freshly and filtered with a 0.45 mm filter. Cells were washed three
times with ice-cold PBS. Motoneurons were lysed with the
cytoplasmic fractionation buffer containing 50 mM Tris
(pH 7.4), 150 mM NaCl, 0.1% NP-40, 1 mM MgCl2 and 1x
Complete Protease inhibitor (Roche) for 10 min on ice. Cells were
scrapped off thoroughly and centrifuged at 500 g for 10 min at
4uC. The supernatant, i.e. the cytoplasmic fraction, was collected.
The pellet was washed three times with 25 ml cytoplasmic buffer to
remove the remaining cytoplasmic fraction. Supernatants were
collected and added to the existing cytoplasmic fraction.
The pellet was lysed with nuclear fractionation buffer compris-
ing 20 mM HEPES (pH 7.4), 400 mM NaCl, 1 mM EDTA,
0.5 mM NaF, 0.5 mM DTT, 2.5% Glycerol, 0.6% CHAPS, 2 U/
100 ml Benzonase and 1x Complete Protease Inhibitor (Roche) for
3 min on ice. The fraction was homogenized, incubated for
10 min on ice and centrifuged at 5000 g for 10 min at 4uC. The
supernatant, i.e. the soluble nuclear fraction, was collected. Total
protein concentration of nuclear and cytosolic fractions was
assessed using the Pierce BCA Protein Assay Kit. Equal amounts
of proteins were loaded for Western Blot analyses. Cytoplasmic
and nuclear fractions were controlled using antibodies against
GAPDH, a tubulin and histone H3 (for more information see the
chapter Western blotting).
Subcellular fractionation of E18 native spinal cord
Spinal cords without vertebrae from E18 mouse embryos were
dissected and washed with PBS three times. Tissues were lysed
with 200 ml cytoplasmic fractionation buffer (see above) for 5 min
on ice. Spinal cords were homogenized and incubated for 5 min
on ice prior to centrifugation at 500 g for 10 min at 4uC.
Supernatants, i.e. cytoplasmic fraction, were collected. In turn, the
pellets were lysed with 100 ml nuclear fractionation buffer (see
above) for 3 min on ice. Again, the pellets were homogenized and
incubated for 10 min on ice. The lysed fractions were centrifuged
at 10 000 g for 10 min at 4uC. The supernatants were collected
serving as soluble nuclear fractions. The insoluble nuclear fraction
was redissolved with RIPA Buffer and further analyzed. Total
protein concentration of nuclear and cytosolic fractions was
assessed using the Pierce BCA Protein Assay Kit. For Western Blot
analyses equal amounts of protein were loaded onto the gel. The
purity of the obtained fractions was controlled by GADPH, a
tubulin and histone H3 (for more information see the chapter
Western blotting).
Coimmunoprecipitation of recombinant proteins
The association between recombinant hnRNP R and SMN was
analyzed by coimmunoprecipitation using GammaBind Plus
Sepharose beads (GE Healthcare). 250 or 500 ng of rhnRNP R
and 250 ng of rSMN were incubated in binding buffer, comprising
50 mM sodium phosphate (pH 8.0), 5% (v/v) glycerol, 50 mM
NaCl and 0.1% Tween, with 20 ml Sepharose beads and 1 mg
antibodies against hnRNP R (ab30930, Abcam), SMN (610647,
BD Bioscience) or non-specific IgG control (anti-GFP, sc-8334,
Santa Cruz) for 1 h at RT. The resin was washed 5 times with
binding buffer to remove unbound proteins. For elution beads
were boiled in 2xLaemmli buffer at 95uC for 5 min. The eluted
proteins were then analyzed by Western blotting (for more
information see the chapter Western blotting). Notably, Light
chain-specific secondary antibodies (Jackson Immunoresearch)
were used for detection since the 55 kDa heavy chain from the
immunoprecipitation would mask the SMN signal.
Immunoprecipitation
Spinal cord without vertebra isolated from E18 mouse embryo
or approximately 500 000 primary motoneurons cultured for
7DIV were used for coimmunoprecipitation experiments. Nuclear
and cytoplasmic proteins were extracted (see above). Fractions
were pre-cleaned with protein G beads (for rabbit IgG antibody)
and protein A beads (for mouse IgG antibody) for 1 h. Afterwards,
the pre-cleaned lysate was incubated with 5 ml rabbit anti-hnRNP
R (abcam, ab30930), 4 ml anti-Smn (BD Biosciences, 610646) and
consistent rabbit and mouse FLAG antibodies, respectively as
negative control for 6 h under rotary agitation at 4uC. Protein G-
agarose beads (Roche) for rabbit antibody and protein A-agarose
beads (Roche) for mouse were washed with PBS and equilibrated
with lysis buffer. The protein and antibody lysate were added to
the respective equilibrated beads and incubated for 1 h under
rotary agitation at 4uC. Subsequently, samples were centrifuged at
500 g for 5 min and the supernatant was removed. Then, beads
were washed thrice with the appropriate lyses buffer and finally
with PBS. The proteins were eluted by boiling the beads with 2x
Laemmli buffer at 90uC for 10 min. Immunoblotting was
performed for hnRNP R and Smn to confirm coimmunoprecipi-
tation.
Western blotting
Primary motoneurons or E18 spinal cord tissue, respectively,
were lysed with cytosolic and nuclear fractionation buffer,
solubilized in Laemmli buffer (125 mM Tris, pH 6.8, 4% SDS,
10% b-mercaptoethanol, 20% glycerol, and 0.004% bromophenol
blue) and boiled for 10 min at 99uC. Proteins were then subjected
to SDS-PAGE, blotted onto PVDF membrane, incubated with the
corresponding antibodies, and developed with either ECL or ECL
Advance Systems (GE Healthcare) on X-ray film (Fuji super RX).
Western blots were scanned and quantified by densitometry
analysis with ImageJ (National Institutes of Health). For Western
Blot analysis the following primary and secondary antibodies were
used: anti-SMN (BD Biosciences, 610646, 1:3000), anti-hnRNP R
(Abcam, ab30930, 1:3000 or polypeptide antiserum aa1-18, ICN,
Wuerzburg, 1:3000), anti-GFP (Santa Cruz, sc-8334, 1:4000),
anti-GAPDH (Millipore, 6C5, 1:4000), anti-a tubulin (T5168,
Sigma, 1:4000), anti-histone H3 (Abcam, ab8580, 1:20 000), anti-
calnexin (Abcam, ab22595, 1:5000), anti-GFP (Santa Cruz, sc-
8334, 1:4000), anti-mouse IgG (Jackson Immunoresearch, 115-
035-003, 1:10000), anti-rabbit IgG (Jackson Immunoresearch,
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111-035-003, 1:10000), anti-mouse light chain-specific (Jackson
Immunoresearch, 111-035-174, 1:10000) and anti-rabbit light
chain-specific (Jackson Immunoresearch, 211-032-171, 1:10000).
Supplementary Material
Supplementary Material is available online at the PLOS ONE
homepage ‘www.plosone.org’.
Supporting Information
Figure S1 Structure of hnRNP R protein and validation
of N-terminal hnRNP R antibody. (A) HnRNP R contains
three RNA-recognition motifs (RRM) and an arginine- and
glycine-rich domain. ICN 1-18 binds to the very N-terminal
region of hnRNP R in contrast to other antibodies which bind to
the C-terminus. (B) Two shRNA binding sites were designed to
deplete hnRNP R protein. Thereby, the one near the 39UTR was
used in this study since it affects all predicted hnRNP R isoforms
identified by database research [92]. The other lentiviral construct
was applied and verified as previously reported [29]. (C)
Representative images of GFP- and sh-hnRNP R-infected
motoneurons cultured for 7DIV on laminin-111 and stained
against hnRNP R, Smn and DAPI (scale bar: 10 mm). Using an
independent N-terminal hnRNP R antibody a significant
reduction (P= 0.0272, t = 5.941, DF=2) of hnRNP R immuno-
reactivity of 52% was detected in sh-hnRNP R-infected moto-
neuron cell bodies (0.4860.09, n= 3, N= 40) in comparison to
GFP-infected control cells (set as ‘1’, n = 3, N= 57). Notably, loss
of hnRNP R did not significantly alter cytosolic Smn signal
intensity (sh-hnRNP R 0.8260.08, P= 0.1426, t = 2.356, DF= 2)
and the number of Smn-positive Gems (GFP 0.8660.24; sh-
hnRNP R 1.0360.24; P= 0.1182, t = 2.645, DF= 2). (D) Pattern
and subcellular distribution of hnRNP R in cell bodies, axons and
axonal growth cones, using the independent N-terminal hnRNP R
antibody, were similar to the results obtained with the ICN 1-18
with a relatively stronger staining in the nucleus. Motoneurons
were cultured for 5DIV on laminin-111. Colocalization analysis of
Smn and hnRNP R revealed also comparable results in soma
(PCC 0.6660.02, MOC 0.7060.01, N=6), axon (PCC
0.2660.02, MOC 0.4860.01, N=7) and axonal growth cone
(PCC 0.2660.05, MOC 0.4760.03, N= 7), as highlighted in
white (right panel) (scale bar: soma, 10 mm; axon and growth cone,
5 mm).
(TIF)
Figure S2 Localization of Smn and hnRNP R in axon
terminals and motor axons in vivo. (A, B) Single optical
slices with 1 mm step size and the corresponding maximum
projections from P4 Diaphragm whole mount preparations stained
against v-BTX, DAPI and (A) Smn or (B) hnRNP R, respectively
(scale bar: 5 mm). Both (A) Smn and (B) hnRNP R immunore-
activity coresided and co-occurred with presynaptic marker
SynPhys. (C) Cross sections from adult sciatic nerve immuno-
stained against hnRNP R, Smn and neurofilament (NF) (scale bar:
5 mm). Superimposed colocalizing points are highlighted in white.
(TIF)
Figure S3 Loss of hnRNP R immunoreactivity after
preabsorption with recombinant protein. (A) hnRNP R
signal was highly reduced after preabsorption of ICN 1-18 with
recombinant hnRNP R protein (B), whereas pre- and postsynaptic
structures were visible, as indicated by synaptophysin and BTX
staining, respectively. DAPI staining showed synaptic nuclei or
nuclei from non-neuronal cells, respectively (scale bar: 5 mm).
(TIF)
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